Advanced HR + HER2 - breast cancer
Also known as: HR+HER2- Advanced Breast Cancer / HR+/HER2- Advanced Breast Cancer / HR+, HER2-, Advanced Breast Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12001 | Abemaciclib | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. |
| DB12015 | Alpelisib | Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... |
| DB01006 | Letrozole | An aromatase inhibitor used to treat breast cancer in postmenopausal women. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17456 | Dalpiciclib | 1 | Not Yet Recruiting | 1 |
| DB06334 | Tucidinostat | 1 | Not Yet Recruiting | 1 |
| DB01590 | Everolimus | 2 | Recruiting | 1 |
| DB06334 | Tucidinostat | 2 | Recruiting | 1 |
| DB12015 | Alpelisib | Not Available | Available | 1 |